Top Markets
Coin of the day
Ceryvyn Therapeutics Ltd Ceryvyn Therapeutics Ltd

Ceryvyn Therapeutics Ltd

OPT
Rank in Stocks #32061
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Share Price
$0.00846342
Last synced: 2026-07-27
Market Cap
$11.27M
Change (1 day)
0.00%
Change (1 year)
-97.73%
Country
AU
Trade Ceryvyn Therapeutics Ltd (OPT)

Category

Stock price history for Ceryvyn Therapeutics Ltd (OPT)
Highest end of day price: $0.01 on 2026-07-01

Lowest end of day price: $0.15 on 1988-01-01
Stock price history of Ceryvyn Therapeutics Ltd from 1988 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -97.42%
2025 -17.38%
2024 36.42%
2023 -47.47%
2022 -29.76%
2021 -42.95%
2020 -21.82%
2019 392.18%
2018 -26.17%
2017 3.79%
2016 123.11%
2015 83.08%
2014 -28.91%
2013 -50.84%
2012 -18.93%
2011 -21.00%
2010 -4.21%
2009 56.43%
2008 -61.92%
2007 -15.72%
2006 48.79%
2005 -49.73%
2004 14.79%
2003 76.25%
2002 -45.07%
2001 -20.31%
2000 -3.29%
1999 342.53%
1998 -1.81%
1997 -40.09%
1996 4.15%
1995 17.13%
1994 73.78%
1993 152.67%
1992 175.78%
1991 -30.00%
1990 -46.43%
1989 9.69%
1988 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$515.58 32.24%
US
$992.01 50.00%
NL
$110.85 -37.09%
AU
$736.64 6.99%
CH
$1.05K -7.52%
KR